Checkpoint Inhibitors Can Cause Thyroid Dysfunction Everyday Health
Checkpoint Inhibitors Can Cause Thyroid Dysfunction Everyday Health MenuNewslettersSearch Cancer Immunotherapy Drugs Used to Treat Cancer Cause More Thyroid Problems Than First Thought As checkpoint inhibitors like Keytruda and Opdivo are used in a wider variety of patients than those who participate in clinical trials, more side effects are emerging. By Shari RoanReviewed: April 8, 2020Fact-CheckedThe thyroid gland appears to be uniquely sensitive to immunotherapy.iStock (2)Thyroid problems related to the use of checkpoint immunotherapies in cancer patients occur more often than previously suspected, according to research released March 31, 2020, by the Endocrine Society. The paper is scheduled for publication in the Journal of the Endocrine Society. The drugs, which include Keytruda (pembrolizumab) and Opdivo (nivolumab), have been used over the past several years to treat a growing number of cancer types and have had particular success in helping patients with melanoma and lung cancer. “They are changing the landscape of cancer therapy and have multiple [U.S.] Food and Drug Administration approvals for both solid and liquid cancers,” says Zoe Quandt, MD, the author of the new study and an endocrinologist with the of University of California in San Francisco.However, the longer the drugs have been in use, the more side effects have emerged in association with them. Thyroid Problems More Common Than Expected To gauge the rate of thyroid problems in patients being treated for cancer, Dr. Quandt and her colleagues looked at the health records of 1,146 patients who received checkpoint immunotherapy drugs for cancer at their institution from 2012 to 2018. The study showed that about 19 percent of patients developed thyroid dysfunction. Among these, 13.4 had hypothyroidism (a condition characterized by low thyroid hormone levels) and 9.5 had hyperthyroidism (production of excessive thyroid hormones). Some patients first experienced hyperthyroidism before converting to hypothyroidsm. In clinical trials involving these drugs, however, the rate of thyroid dysfunction was lower. Only 6.6 percent of patients developed hypothyroidism and 2.9 percent had hyperthyroidism. “We found a much higher percent of thyroid dysfunction than we were expecting,” Quandt says. “It appears to be much more common than was previously reported in clinical trials.” Thyroid problems that arise during checkpoint inhibitor therapy appear to be permanent, Quandt says. RELATED: Cancer News Update: Acupuncture Helps Cancer-Related Pain, Thyroid Cancer on the Decline, and More A Growing Side Effect Profile Checkpoint Inhibitors work by helping the immune system recognize and attack cancer cells. Part of their appeal is that they lack some of the more harsh side effects common to chemotherapy and radiation — toxic effects that can make patients miserable during cancer treatment. But as more immunotherapy drugs become available and are used in the real world, additional information is accumulating about their side effects. Side effect rates may be higher in the real world than in clinical trials, says Quandt, because some types of patients are restricted from entering clinical trials. “In the real world, we have fewer restrictions on who can get these drugs. We’re giving it to people with other [health] conditions,” she says. “As we give these drugs to a broader population, we are seeing more of these results.” The Unique Sensitivity of the Thyroid Gland It’s not clear why thyroid problems are appearing so commonly in patients taking checkpoint inhibitors, Quandt says. One possible explanation is that some people have mild undiagnosed thyroid dysfunction before being diagnosed with cancer. The immune checkpoint inhibitors, says Quandt, “could activate an underlying predisposition” to thyroid disease. It’s also possible that cancer patients are taking other medication that also interferes with normal thyroid function. For example, she said, renal cell carcinoma patients commonly take a kinase inhibitor that can also cause thyroid dysfunction. The study did not find a link between thyroid dysfunction and specific immune checkpoint inhibitors. However, thyroid dysfunction was more common in patients who received a combination of Opdivo and Yervoy (ipilimumab) compared with those who took either Keytruda, Opdivo, or Yervoy alone. The study is the first to show that thyroid problems may be more common in people with certain types of cancer. For example, thyroid dysfunction was found in 10 percent of patients with the brain tumor glioblastoma compared with 40 percent for people with renal cell cancer, a type of kidney cancer. More research is needed to examine why people with certain types of cancers may be more likely to experience thyroid problems on a checkpoint inhibitor, Quandt says. RELATED: How Psoriasis and Your Thyroid May Be Linked Guarding the Thyroid Gland It’s important for patients, oncologists, and endocrinologists to address any thyroid symptoms, Quandt says. Patients with cancer can experience weight loss, insomnia, and even atrial fibrillation from hyperthyroidsim, and fatigue and constipation from hypothyroidism. “An untreated patient can feel pretty awful,” she said. She recommends that oncologists conduct thyroid function tests before starting immunotherapy. “If the thyroid function is even a little abnormal prior to starting therapy, there is an increased risk of thyroid dysfunction developing, according to another study,” she says. Oncologists often treat thyroid problems that arise during cancer treatment, she said. “Many oncologists feel comfortable dealing with this on their own, and they usually do a good job of it as long as they are attentive to the labs [thyroid function tests results]. I think it is appropriate to refer to an endocrinologist for any extra support.” NEWSLETTERS Sign up for our Cancer Care Newsletter SubscribeBy subscribing you agree to the Terms of Use and Privacy Policy. The Latest in Cancer New Guidelines Recommend Best Uses of Acupuncture Massage and Other Non-Drug Treatments for Cancer Pain Leading organizations say complementary therapies such as reflexology and hypnosis may provide pain relief for some cancers.By Susan K. TreimanOctober 4, 2022 Is Chemotherapy Bringing You Down Research shows that chemotherapy can cause depression. Fortunately, you can take steps to manage your mental well-being during treatment.By Carolyn BernhardtSeptember 15, 2022 Ultra-Processed Foods and Drinks Linked to Colorectal Cancer and Early DeathTwo new studies suggest that ‘convenience’ foods may come at a high cost to our health.By Becky UphamSeptember 14, 2022 Cancer Cases Rising Dramatically in Adults Under 50More sedentary lifestyles, less-healthy eating habits, and increased screening may all play a role, a new study suggests.By Lisa RapaportSeptember 12, 2022 Does the Ink Used in Tattoos Pose a Health Risk New research finds unreliable labels and potentially concerning ingredients in many popular tattoo inks.By Becky UphamAugust 30, 2022 Nearly Half of All Cancer Deaths Around the World Could Be PreventedSmoking, drinking too much alcohol, and excess weight are leading causes of preventable cancer deaths, according to new global study.By Becky UphamAugust 30, 2022 Spotlight On Survivor FitnessGetting in shape after cancer treatment can be part of the path toward finding yourself again. Aaron Grunke has created a foundation to help survivors...By Lambeth HochwaldJuly 25, 2022 2-Step Gene Sequencing Shows Who May Respond to Cancer ImmunotherapyScientists used a process known as whole exome sequencing to examine 20,000 genes for a clearer picture of who may benefit from targeted cancer drugs ...By Lisa RapaportJuly 13, 2022 Weight Loss Surgery Is Tied to a Lower Risk of Obesity-Related CancersPeople with obesity who undergo bariatric surgery to lose weight have a lower risk of developing and dying of cancer, a new study suggests.By Lisa RapaportJune 8, 2022 Experimental Rectal Cancer Drug Eliminates Tumors in Small TrialEvery rectal cancer patient in the small trial who took the experimental drug dostarlimab for 6 months went into complete remission.By Lisa RapaportJune 7, 2022 MORE IN What to Know About Thyroid Eye Disease Graves Ophthalmopathy Hypothyroidism and Hyperthyroidism What s the Difference Hyperthyroidism Causes and Risk Factors